Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Depiction of Aging-Based Molecular Phenotypes With Diverse Clinical Prognosis and Immunological Features in Gastric Cancer. | Front Med (Lausanne) | 2021 | 35178409 | PubTator, text mining | PubMed |
| Insights Into the Emergence of Paroxysmal Nocturnal Hemoglobinuria. | Front Immunol | 2021 | 35154088 | PubTator, text mining | PubMed |
| Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy. | Front Mol Biosci | 2021 | 35127816 | PubTator, text mining | PubMed |
| Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma. | Front Cell Dev Biol | 2021 | 35127727 | PubTator, text mining | PubMed |
| Prognostic Implication and Oncogenic Role of PNPO in Pan-Cancer. | Front Cell Dev Biol | 2021 | 35127701 | PubTator, text mining | PubMed |
| EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer. | Front Genet | 2021 | 35126464 | PubTator, text mining | PubMed |
| The transformative impact of extracellular vesicles on developing sperm. | Reprod Fertil | 2021 | 35118397 | PubTator, text mining | PubMed |
| Exhausted and Apoptotic BALF T Cells in Proinflammatory Airway Milieu at Acute Phase of Severe Mycoplasma Pneumoniae Pneumonia in Children. | Front Immunol | 2021 | 35111152 | PubTator, text mining | PubMed |
| Characterization of an Aging-Based Diagnostic Gene Signature and Molecular Subtypes With Diverse Immune Infiltrations in Atherosclerosis. | Front Mol Biosci | 2021 | 35096968 | PubTator, text mining | PubMed |
| When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors. | Front Immunol | 2021 | 35095876 | PubTator, text mining | PubMed |
| Characterization of m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration in Ovarian Cancer. | Front Cell Dev Biol | 2021 | 35087835 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Cell Cycle-Related Genes in Patients With Prostate Cancer. | Front Oncol | 2021 | 35087757 | PubTator, text mining | PubMed |
| Natural Killer Cells in the Malignant Niche of Multiple Myeloma. | Front Immunol | 2021 | 35087536 | PubTator, text mining | PubMed |
| Back to the Future: Spatiotemporal Determinants of NK Cell Antitumor Function. | Front Immunol | 2021 | 35082797 | PubTator, text mining | PubMed |
| Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma. | Front Mol Biosci | 2021 | 35071320 | PubTator, text mining | PubMed |
| Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma. | World J Gastrointest Oncol | 2021 | 35070039 | PubTator, text mining | PubMed |
| Spectrum of Neurological Symptoms in Glycosylphosphatidylinositol Biosynthesis Defects: Systematic Review. | Front Neurol | 2021 | 35058872 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Immune Implication and Prognostic Value of IFI44L in Non-Small Cell Lung Cancer. | Front Oncol | 2021 | 35047409 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Prognostic Microenvironment-Related Genes in Invasive Breast Cancer. | Front Oncol | 2021 | 35047378 | PubTator, text mining | PubMed |
| Single-Cell Analysis Reveals the Immune Characteristics of Myeloid Cells and Memory T Cells in Recovered COVID-19 Patients With Different Severities. | Front Immunol | 2021 | 35046942 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=56